Joseph Scandura, MD, PhD, Weill Cornell Medicine and the New York Presbyterian Hospital, New York City, NY, comments on the key role of megakaryocytes in myeloproliferative neoplasms (MPNs), discussing their impact on hematopoietic stem cells, fibrosis, and microvessel density. This interview took place at the 14th International Congress on Myeloproliferative Neoplasms (MPN Congress) held in New York City, NY.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть